GPT and metabolic dysfunction-associated steatotic liver disease: This finding was in line with a recent trial in patients with NAFLD, which showed that 250 mg/day of curcumin therapy for 8 weeks could cause a significant reduction in ALT (Mirhafez et al., 2021).